nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefenamic acid—AKR1C2—polycystic ovary syndrome	0.451	0.536	CbGaD
Mefenamic acid—AKR1C1—polycystic ovary syndrome	0.247	0.294	CbGaD
Mefenamic acid—AKR1C3—polycystic ovary syndrome	0.143	0.171	CbGaD
Mefenamic acid—PTGS2—ovarian follicle—polycystic ovary syndrome	0.00434	0.155	CbGeAlD
Mefenamic acid—AKR1C2—adrenal gland—polycystic ovary syndrome	0.00329	0.117	CbGeAlD
Mefenamic acid—CYP2C9—urine—polycystic ovary syndrome	0.00208	0.0743	CbGeAlD
Mefenamic acid—AKR1C3—adrenal cortex—polycystic ovary syndrome	0.00142	0.0508	CbGeAlD
Mefenamic acid—AKR1C3—endometrium—polycystic ovary syndrome	0.00127	0.0454	CbGeAlD
Mefenamic acid—Acetylsalicylic acid—AKR1C1—polycystic ovary syndrome	0.0012	0.369	CrCbGaD
Mefenamic acid—AKR1C3—uterus—polycystic ovary syndrome	0.00117	0.0418	CbGeAlD
Mefenamic acid—AKR1C3—pituitary gland—polycystic ovary syndrome	0.00115	0.041	CbGeAlD
Mefenamic acid—AKR1C3—adipose tissue—polycystic ovary syndrome	0.00114	0.0409	CbGeAlD
Mefenamic acid—Gastrointestinal symptom NOS—Metformin—polycystic ovary syndrome	0.00104	0.088	CcSEcCtD
Mefenamic acid—AKR1C3—adrenal gland—polycystic ovary syndrome	0.00103	0.0367	CbGeAlD
Mefenamic acid—Salicylic acid—AKR1C1—polycystic ovary syndrome	0.000989	0.304	CrCbGaD
Mefenamic acid—AKR1C3—female gonad—polycystic ovary syndrome	0.000957	0.0342	CbGeAlD
Mefenamic acid—AKR1C3—vagina—polycystic ovary syndrome	0.000951	0.034	CbGeAlD
Mefenamic acid—Meclofenamic acid—AKR1C3—polycystic ovary syndrome	0.00092	0.283	CrCbGaD
Mefenamic acid—Heartburn—Metformin—polycystic ovary syndrome	0.000893	0.0752	CcSEcCtD
Mefenamic acid—PTGS2—embryo—polycystic ovary syndrome	0.000587	0.021	CbGeAlD
Mefenamic acid—CYP2C8—endometrium—polycystic ovary syndrome	0.000554	0.0198	CbGeAlD
Mefenamic acid—Ear pain—Metformin—polycystic ovary syndrome	0.000523	0.044	CcSEcCtD
Mefenamic acid—CYP2C8—pituitary gland—polycystic ovary syndrome	0.000501	0.0179	CbGeAlD
Mefenamic acid—PTGS2—adrenal cortex—polycystic ovary syndrome	0.000481	0.0172	CbGeAlD
Mefenamic acid—Renal impairment—Metformin—polycystic ovary syndrome	0.000469	0.0395	CcSEcCtD
Mefenamic acid—PTGS1—endometrium—polycystic ovary syndrome	0.000449	0.016	CbGeAlD
Mefenamic acid—PTGS2—endometrium—polycystic ovary syndrome	0.000429	0.0153	CbGeAlD
Mefenamic acid—CYP2C8—vagina—polycystic ovary syndrome	0.000415	0.0148	CbGeAlD
Mefenamic acid—PTGS1—uterus—polycystic ovary syndrome	0.000414	0.0148	CbGeAlD
Mefenamic acid—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.000412	0.0347	CcSEcCtD
Mefenamic acid—PTGS1—pituitary gland—polycystic ovary syndrome	0.000407	0.0145	CbGeAlD
Mefenamic acid—PTGS1—adipose tissue—polycystic ovary syndrome	0.000405	0.0145	CbGeAlD
Mefenamic acid—PTGS2—uterus—polycystic ovary syndrome	0.000396	0.0141	CbGeAlD
Mefenamic acid—PTGS2—pituitary gland—polycystic ovary syndrome	0.000389	0.0139	CbGeAlD
Mefenamic acid—CYP2C8—endocrine gland—polycystic ovary syndrome	0.000388	0.0139	CbGeAlD
Mefenamic acid—PTGS2—adipose tissue—polycystic ovary syndrome	0.000387	0.0138	CbGeAlD
Mefenamic acid—Pancreatitis—Metformin—polycystic ovary syndrome	0.000378	0.0318	CcSEcCtD
Mefenamic acid—PTGS1—adrenal gland—polycystic ovary syndrome	0.000363	0.013	CbGeAlD
Mefenamic acid—PTGS2—adrenal gland—polycystic ovary syndrome	0.000347	0.0124	CbGeAlD
Mefenamic acid—CYP2C9—endocrine gland—polycystic ovary syndrome	0.000345	0.0123	CbGeAlD
Mefenamic acid—Drowsiness—Metformin—polycystic ovary syndrome	0.000344	0.029	CcSEcCtD
Mefenamic acid—PTGS1—female gonad—polycystic ovary syndrome	0.000339	0.0121	CbGeAlD
Mefenamic acid—PTGS1—vagina—polycystic ovary syndrome	0.000337	0.012	CbGeAlD
Mefenamic acid—PTGS2—female gonad—polycystic ovary syndrome	0.000324	0.0116	CbGeAlD
Mefenamic acid—PTGS2—vagina—polycystic ovary syndrome	0.000322	0.0115	CbGeAlD
Mefenamic acid—PTGS1—endocrine gland—polycystic ovary syndrome	0.000315	0.0113	CbGeAlD
Mefenamic acid—Hepatitis—Metformin—polycystic ovary syndrome	0.000308	0.026	CcSEcCtD
Mefenamic acid—PTGS2—endocrine gland—polycystic ovary syndrome	0.000301	0.0108	CbGeAlD
Mefenamic acid—Flatulence—Metformin—polycystic ovary syndrome	0.000265	0.0223	CcSEcCtD
Mefenamic acid—Vision blurred—Metformin—polycystic ovary syndrome	0.000253	0.0213	CcSEcCtD
Mefenamic acid—Tremor—Metformin—polycystic ovary syndrome	0.000252	0.0212	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.000249	0.021	CcSEcCtD
Mefenamic acid—Malaise—Metformin—polycystic ovary syndrome	0.000242	0.0204	CcSEcCtD
Mefenamic acid—Syncope—Metformin—polycystic ovary syndrome	0.000241	0.0203	CcSEcCtD
Mefenamic acid—Palpitations—Metformin—polycystic ovary syndrome	0.000237	0.02	CcSEcCtD
Mefenamic acid—Loss of consciousness—Metformin—polycystic ovary syndrome	0.000236	0.0199	CcSEcCtD
Mefenamic acid—Hypertension—Metformin—polycystic ovary syndrome	0.000232	0.0195	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.000227	0.0191	CcSEcCtD
Mefenamic acid—Discomfort—Metformin—polycystic ovary syndrome	0.000226	0.019	CcSEcCtD
Mefenamic acid—Oedema—Metformin—polycystic ovary syndrome	0.000219	0.0185	CcSEcCtD
Mefenamic acid—Infection—Metformin—polycystic ovary syndrome	0.000218	0.0183	CcSEcCtD
Mefenamic acid—Shock—Metformin—polycystic ovary syndrome	0.000216	0.0182	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.000215	0.0181	CcSEcCtD
Mefenamic acid—Skin disorder—Metformin—polycystic ovary syndrome	0.000213	0.0179	CcSEcCtD
Mefenamic acid—Anorexia—Metformin—polycystic ovary syndrome	0.000209	0.0176	CcSEcCtD
Mefenamic acid—Hypotension—Metformin—polycystic ovary syndrome	0.000205	0.0173	CcSEcCtD
Mefenamic acid—Paraesthesia—Metformin—polycystic ovary syndrome	0.000197	0.0166	CcSEcCtD
Mefenamic acid—Dyspnoea—Metformin—polycystic ovary syndrome	0.000195	0.0165	CcSEcCtD
Mefenamic acid—Somnolence—Metformin—polycystic ovary syndrome	0.000195	0.0164	CcSEcCtD
Mefenamic acid—Dyspepsia—Metformin—polycystic ovary syndrome	0.000193	0.0163	CcSEcCtD
Mefenamic acid—Decreased appetite—Metformin—polycystic ovary syndrome	0.000191	0.0161	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000189	0.0159	CcSEcCtD
Mefenamic acid—Constipation—Metformin—polycystic ovary syndrome	0.000187	0.0158	CcSEcCtD
Mefenamic acid—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000181	0.0152	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000179	0.0151	CcSEcCtD
Mefenamic acid—Urticaria—Metformin—polycystic ovary syndrome	0.000174	0.0147	CcSEcCtD
Mefenamic acid—Abdominal pain—Metformin—polycystic ovary syndrome	0.000173	0.0146	CcSEcCtD
Mefenamic acid—Asthenia—Metformin—polycystic ovary syndrome	0.000157	0.0132	CcSEcCtD
Mefenamic acid—Pruritus—Metformin—polycystic ovary syndrome	0.000155	0.0131	CcSEcCtD
Mefenamic acid—Diarrhoea—Metformin—polycystic ovary syndrome	0.00015	0.0126	CcSEcCtD
Mefenamic acid—Dizziness—Metformin—polycystic ovary syndrome	0.000145	0.0122	CcSEcCtD
Mefenamic acid—Diclofenac—CYP1A1—polycystic ovary syndrome	0.000144	0.0443	CrCbGaD
Mefenamic acid—Vomiting—Metformin—polycystic ovary syndrome	0.000139	0.0117	CcSEcCtD
Mefenamic acid—Rash—Metformin—polycystic ovary syndrome	0.000138	0.0116	CcSEcCtD
Mefenamic acid—Dermatitis—Metformin—polycystic ovary syndrome	0.000138	0.0116	CcSEcCtD
Mefenamic acid—Headache—Metformin—polycystic ovary syndrome	0.000137	0.0116	CcSEcCtD
Mefenamic acid—Nausea—Metformin—polycystic ovary syndrome	0.00013	0.011	CcSEcCtD
Mefenamic acid—CYP2C8—Metabolism—NMNAT3—polycystic ovary syndrome	2.15e-05	0.000185	CbGpPWpGaD
Mefenamic acid—PTGS1—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	2.1e-05	0.000181	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—INSR—polycystic ovary syndrome	2.08e-05	0.00018	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—MTHFR—polycystic ovary syndrome	2.06e-05	0.000178	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	2.05e-05	0.000177	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	2.05e-05	0.000177	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—GNAS—polycystic ovary syndrome	2.05e-05	0.000176	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—IRS1—polycystic ovary syndrome	2.04e-05	0.000176	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—TH—polycystic ovary syndrome	2.02e-05	0.000174	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PNPLA2—polycystic ovary syndrome	2.02e-05	0.000174	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	2e-05	0.000173	CbGpPWpGaD
Mefenamic acid—CYP2C9—Biological oxidations—CYP1A1—polycystic ovary syndrome	1.99e-05	0.000171	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	1.98e-05	0.000171	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—LPCAT2—polycystic ovary syndrome	1.97e-05	0.00017	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—SUOX—polycystic ovary syndrome	1.97e-05	0.00017	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	1.96e-05	0.000169	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—SLC2A4—polycystic ovary syndrome	1.96e-05	0.000169	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—INS—polycystic ovary syndrome	1.96e-05	0.000169	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.95e-05	0.000168	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.95e-05	0.000168	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	1.94e-05	0.000168	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	1.94e-05	0.000167	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—PGR—polycystic ovary syndrome	1.93e-05	0.000166	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—NRG1—polycystic ovary syndrome	1.91e-05	0.000165	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—SRD5A1—polycystic ovary syndrome	1.91e-05	0.000165	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—AKR1C2—polycystic ovary syndrome	1.91e-05	0.000165	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—TEAD2—polycystic ovary syndrome	1.91e-05	0.000165	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—AKT2—polycystic ovary syndrome	1.89e-05	0.000163	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—NCOR1—polycystic ovary syndrome	1.87e-05	0.000161	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—CYP19A1—polycystic ovary syndrome	1.84e-05	0.000159	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—NRG1—polycystic ovary syndrome	1.84e-05	0.000158	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	1.84e-05	0.000158	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	1.83e-05	0.000158	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—ISYNA1—polycystic ovary syndrome	1.83e-05	0.000158	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—STAR—polycystic ovary syndrome	1.82e-05	0.000157	CbGpPWpGaD
Mefenamic acid—CYP2C8—Biological oxidations—POMC—polycystic ovary syndrome	1.82e-05	0.000157	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	1.81e-05	0.000156	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	1.8e-05	0.000155	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—SERPINE1—polycystic ovary syndrome	1.8e-05	0.000155	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—PLAT—polycystic ovary syndrome	1.79e-05	0.000155	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—GHRL—polycystic ovary syndrome	1.79e-05	0.000155	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	1.79e-05	0.000154	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—NMNAT3—polycystic ovary syndrome	1.75e-05	0.000151	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	1.73e-05	0.000149	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—ATF1—polycystic ovary syndrome	1.71e-05	0.000147	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—PPARG—polycystic ovary syndrome	1.67e-05	0.000144	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	1.67e-05	0.000144	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.67e-05	0.000144	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	1.67e-05	0.000144	CbGpPWpGaD
Mefenamic acid—PTGS2—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	1.66e-05	0.000143	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—MTHFR—polycystic ovary syndrome	1.65e-05	0.000143	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—POMC—polycystic ovary syndrome	1.65e-05	0.000142	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—GNAS—polycystic ovary syndrome	1.65e-05	0.000142	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—IRS2—polycystic ovary syndrome	1.64e-05	0.000141	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—INS—polycystic ovary syndrome	1.64e-05	0.000141	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	1.63e-05	0.000141	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—HMMR—polycystic ovary syndrome	1.63e-05	0.00014	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—RPL37A—polycystic ovary syndrome	1.62e-05	0.00014	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—LEP—polycystic ovary syndrome	1.6e-05	0.000138	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PNPLA2—polycystic ovary syndrome	1.6e-05	0.000138	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—LPCAT2—polycystic ovary syndrome	1.6e-05	0.000138	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—SUOX—polycystic ovary syndrome	1.6e-05	0.000138	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	1.58e-05	0.000136	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	1.58e-05	0.000136	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—NGFR—polycystic ovary syndrome	1.58e-05	0.000136	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—IRS2—polycystic ovary syndrome	1.57e-05	0.000136	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—NCOR1—polycystic ovary syndrome	1.57e-05	0.000135	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—PRL—polycystic ovary syndrome	1.56e-05	0.000135	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—TEAD2—polycystic ovary syndrome	1.55e-05	0.000134	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—AKR1C2—polycystic ovary syndrome	1.55e-05	0.000134	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—HSD3B1—polycystic ovary syndrome	1.55e-05	0.000134	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—HMMR—polycystic ovary syndrome	1.54e-05	0.000133	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	1.53e-05	0.000132	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—SRD5A1—polycystic ovary syndrome	1.52e-05	0.000131	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	1.49e-05	0.000129	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ISYNA1—polycystic ovary syndrome	1.49e-05	0.000128	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—CYP1A1—polycystic ovary syndrome	1.49e-05	0.000128	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.48e-05	0.000128	CbGpPWpGaD
Mefenamic acid—CYP2C9—Biological oxidations—POMC—polycystic ovary syndrome	1.48e-05	0.000128	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	1.47e-05	0.000127	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	1.45e-05	0.000125	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	1.45e-05	0.000125	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—STAR—polycystic ovary syndrome	1.45e-05	0.000125	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	1.43e-05	0.000123	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—IRS1—polycystic ovary syndrome	1.43e-05	0.000123	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—LHB—polycystic ovary syndrome	1.41e-05	0.000122	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—MTHFR—polycystic ovary syndrome	1.39e-05	0.000119	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—HSD3B2—polycystic ovary syndrome	1.38e-05	0.000119	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—POMC—polycystic ovary syndrome	1.38e-05	0.000119	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—GNAS—polycystic ovary syndrome	1.38e-05	0.000119	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—IRS1—polycystic ovary syndrome	1.37e-05	0.000118	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—INS—polycystic ovary syndrome	1.37e-05	0.000118	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	1.36e-05	0.000117	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—AKR1C1—polycystic ovary syndrome	1.34e-05	0.000115	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—IGF1—polycystic ovary syndrome	1.32e-05	0.000114	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—AKT2—polycystic ovary syndrome	1.32e-05	0.000114	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—INS—polycystic ovary syndrome	1.32e-05	0.000113	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—IL6—polycystic ovary syndrome	1.32e-05	0.000113	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.31e-05	0.000113	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PNPLA2—polycystic ovary syndrome	1.3e-05	0.000112	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	1.29e-05	0.000112	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—HMMR—polycystic ovary syndrome	1.29e-05	0.000111	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	1.29e-05	0.000111	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—NRG1—polycystic ovary syndrome	1.29e-05	0.000111	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—AKT2—polycystic ovary syndrome	1.27e-05	0.00011	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—AKR1C1—polycystic ovary syndrome	1.27e-05	0.000109	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—TEAD2—polycystic ovary syndrome	1.26e-05	0.000109	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—AKR1C2—polycystic ovary syndrome	1.26e-05	0.000109	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.26e-05	0.000108	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—SRD5A1—polycystic ovary syndrome	1.23e-05	0.000106	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—SULT2A1—polycystic ovary syndrome	1.23e-05	0.000106	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—HSD3B1—polycystic ovary syndrome	1.23e-05	0.000106	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	1.22e-05	0.000105	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	1.22e-05	0.000105	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—SERPINE1—polycystic ovary syndrome	1.21e-05	0.000104	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	1.2e-05	0.000103	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—RRM2—polycystic ovary syndrome	1.19e-05	0.000103	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—STAR—polycystic ovary syndrome	1.18e-05	0.000102	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—FGF18—polycystic ovary syndrome	1.18e-05	0.000102	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—RBP4—polycystic ovary syndrome	1.17e-05	0.000101	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	1.16e-05	0.0001	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	1.15e-05	9.94e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—YAP1—polycystic ovary syndrome	1.15e-05	9.91e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—PPARG—polycystic ovary syndrome	1.12e-05	9.69e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—LHB—polycystic ovary syndrome	1.12e-05	9.68e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—POMC—polycystic ovary syndrome	1.11e-05	9.56e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—NAMPT—polycystic ovary syndrome	1.1e-05	9.52e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—IRS2—polycystic ovary syndrome	1.1e-05	9.5e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—INS—polycystic ovary syndrome	1.1e-05	9.5e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.1e-05	9.47e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—HSD3B2—polycystic ovary syndrome	1.1e-05	9.46e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—CYP11A1—polycystic ovary syndrome	1.09e-05	9.41e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.08e-05	9.34e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—LEP—polycystic ovary syndrome	1.08e-05	9.3e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—GAB1—polycystic ovary syndrome	1.07e-05	9.27e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—AKR1C1—polycystic ovary syndrome	1.06e-05	9.16e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	1.06e-05	9.14e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—HMMR—polycystic ovary syndrome	1.05e-05	9.05e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—NAMPT—polycystic ovary syndrome	1.05e-05	9.03e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—AKR1C3—polycystic ovary syndrome	1.03e-05	8.88e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—CYP17A1—polycystic ovary syndrome	1.01e-05	8.74e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	1e-05	8.66e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—HSD3B1—polycystic ovary syndrome	1e-05	8.63e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	9.9e-06	8.53e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—SULT2A1—polycystic ovary syndrome	9.78e-06	8.43e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—AKR1C3—polycystic ovary syndrome	9.77e-06	8.42e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—IRS1—polycystic ovary syndrome	9.62e-06	8.3e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—TNRC6B—polycystic ovary syndrome	9.61e-06	8.29e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	9.59e-06	8.26e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	9.47e-06	8.17e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—RRM2—polycystic ovary syndrome	9.47e-06	8.16e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	9.38e-06	8.09e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—POMC—polycystic ovary syndrome	9.27e-06	7.99e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—INS—polycystic ovary syndrome	9.21e-06	7.95e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—LHB—polycystic ovary syndrome	9.13e-06	7.87e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—YAP1—polycystic ovary syndrome	9.13e-06	7.87e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—HSD3B2—polycystic ovary syndrome	8.93e-06	7.7e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—IGF1—polycystic ovary syndrome	8.91e-06	7.69e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—AKT2—polycystic ovary syndrome	8.91e-06	7.68e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—TH—polycystic ovary syndrome	8.78e-06	7.57e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—NAMPT—polycystic ovary syndrome	8.77e-06	7.56e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	8.72e-06	7.52e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CYP11A1—polycystic ovary syndrome	8.66e-06	7.47e-05	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—VEGFA—polycystic ovary syndrome	8.65e-06	7.46e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—AKR1C1—polycystic ovary syndrome	8.64e-06	7.45e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	8.6e-06	7.41e-05	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—IL6—polycystic ovary syndrome	8.55e-06	7.37e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	8.54e-06	7.37e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—SLC2A4—polycystic ovary syndrome	8.54e-06	7.36e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.46e-06	7.3e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—TCF7L2—polycystic ovary syndrome	8.23e-06	7.1e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—AKR1C3—polycystic ovary syndrome	8.18e-06	7.05e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	8.15e-06	7.03e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—SLC2A4—polycystic ovary syndrome	8.09e-06	6.98e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	8.06e-06	6.95e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CYP17A1—polycystic ovary syndrome	8.05e-06	6.94e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—CYP19A1—polycystic ovary syndrome	8.03e-06	6.92e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—SULT2A1—polycystic ovary syndrome	7.96e-06	6.86e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—PRL—polycystic ovary syndrome	7.72e-06	6.66e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—RRM2—polycystic ovary syndrome	7.7e-06	6.64e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	7.64e-06	6.58e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	7.43e-06	6.41e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—YAP1—polycystic ovary syndrome	7.43e-06	6.4e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	7.26e-06	6.26e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—GNAS—polycystic ovary syndrome	7.16e-06	6.18e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—NAMPT—polycystic ovary syndrome	7.14e-06	6.15e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	7.09e-06	6.12e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CYP11A1—polycystic ovary syndrome	7.05e-06	6.08e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	7.04e-06	6.07e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	7e-06	6.03e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—TH—polycystic ovary syndrome	6.97e-06	6.01e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—NCOR1—polycystic ovary syndrome	6.82e-06	5.88e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—SLC2A4—polycystic ovary syndrome	6.78e-06	5.84e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—AKR1C3—polycystic ovary syndrome	6.65e-06	5.74e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CYP17A1—polycystic ovary syndrome	6.55e-06	5.65e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	6.47e-06	5.58e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—CYP1A1—polycystic ovary syndrome	6.47e-06	5.58e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—NCOR1—polycystic ovary syndrome	6.47e-06	5.58e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CYP19A1—polycystic ovary syndrome	6.37e-06	5.49e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—NRG1—polycystic ovary syndrome	6.35e-06	5.48e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	6.27e-06	5.41e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	6.04e-06	5.21e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—MTHFR—polycystic ovary syndrome	6.03e-06	5.2e-05	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—IL6—polycystic ovary syndrome	5.98e-06	5.16e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.82e-06	5.02e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	5.81e-06	5.01e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	5.77e-06	4.98e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—IL6—polycystic ovary syndrome	5.75e-06	4.96e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	5.74e-06	4.95e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—MTHFR—polycystic ovary syndrome	5.72e-06	4.93e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	5.69e-06	4.91e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—GNAS—polycystic ovary syndrome	5.69e-06	4.9e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—TH—polycystic ovary syndrome	5.67e-06	4.89e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—SLC2A4—polycystic ovary syndrome	5.51e-06	4.75e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—IRS2—polycystic ovary syndrome	5.44e-06	4.69e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—NCOR1—polycystic ovary syndrome	5.42e-06	4.67e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	5.42e-06	4.67e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	5.33e-06	4.6e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CYP19A1—polycystic ovary syndrome	5.18e-06	4.47e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CYP1A1—polycystic ovary syndrome	5.14e-06	4.43e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PPARG—polycystic ovary syndrome	4.89e-06	4.22e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—POMC—polycystic ovary syndrome	4.82e-06	4.16e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—INS—polycystic ovary syndrome	4.8e-06	4.14e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—MTHFR—polycystic ovary syndrome	4.79e-06	4.13e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—IRS1—polycystic ovary syndrome	4.75e-06	4.09e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—GNAS—polycystic ovary syndrome	4.63e-06	3.99e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—TH—polycystic ovary syndrome	4.61e-06	3.98e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—INS—polycystic ovary syndrome	4.55e-06	3.92e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	4.49e-06	3.87e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—NCOR1—polycystic ovary syndrome	4.41e-06	3.8e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—AKT2—polycystic ovary syndrome	4.39e-06	3.79e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	4.22e-06	3.64e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CYP1A1—polycystic ovary syndrome	4.18e-06	3.6e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—SERPINE1—polycystic ovary syndrome	4.18e-06	3.6e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—IL6—polycystic ovary syndrome	4.03e-06	3.47e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—MTHFR—polycystic ovary syndrome	3.9e-06	3.36e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PPARG—polycystic ovary syndrome	3.88e-06	3.35e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—POMC—polycystic ovary syndrome	3.83e-06	3.3e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—INS—polycystic ovary syndrome	3.81e-06	3.28e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	3.77e-06	3.25e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	3.59e-06	3.09e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	3.4e-06	2.93e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	3.17e-06	2.73e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PPARG—polycystic ovary syndrome	3.16e-06	2.72e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—POMC—polycystic ovary syndrome	3.12e-06	2.69e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—INS—polycystic ovary syndrome	3.1e-06	2.67e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	2.57e-06	2.22e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	2.54e-06	2.19e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—INS—polycystic ovary syndrome	2.52e-06	2.17e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—IL6—polycystic ovary syndrome	1.99e-06	1.71e-05	CbGpPWpGaD
